COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 75 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $854,619 | -5.2% | 38,238 | -8.9% | 0.00% | 0.0% |
| Q2 2023 | $901,613 | -7.2% | 41,955 | +3.5% | 0.00% | 0.0% |
| Q1 2023 | $972,003 | +0.8% | 40,517 | -2.6% | 0.00% | -50.0% |
| Q4 2022 | $964,633 | +46.2% | 41,579 | +1.0% | 0.00% | +100.0% |
| Q3 2022 | $660,000 | -13.2% | 41,180 | -4.0% | 0.00% | 0.0% |
| Q2 2022 | $760,000 | -10.8% | 42,915 | +2.6% | 0.00% | 0.0% |
| Q1 2022 | $852,000 | +0.2% | 41,823 | -8.1% | 0.00% | 0.0% |
| Q4 2021 | $850,000 | -4.0% | 45,487 | +1.4% | 0.00% | 0.0% |
| Q3 2021 | $885,000 | -22.8% | 44,851 | -7.6% | 0.00% | 0.0% |
| Q2 2021 | $1,147,000 | -6.5% | 48,520 | -6.3% | 0.00% | -50.0% |
| Q1 2021 | $1,227,000 | +18.3% | 51,758 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $1,037,000 | -3.8% | 51,758 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $1,078,000 | +19.0% | 51,758 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $906,000 | +14.2% | 51,758 | +6.6% | 0.00% | 0.0% |
| Q1 2020 | $793,000 | -21.5% | 48,541 | -1.1% | 0.00% | 0.0% |
| Q4 2019 | $1,010,000 | +75.7% | 49,089 | -2.0% | 0.00% | +100.0% |
| Q3 2019 | $575,000 | -11.7% | 50,081 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $651,000 | -4.3% | 49,483 | +10.1% | 0.00% | 0.0% |
| Q1 2019 | $680,000 | -14.9% | 44,931 | -3.5% | 0.00% | -50.0% |
| Q4 2018 | $799,000 | +20.7% | 46,546 | +3.6% | 0.00% | +100.0% |
| Q3 2018 | $662,000 | -38.2% | 44,908 | -0.0% | 0.00% | -50.0% |
| Q2 2018 | $1,071,000 | +9.8% | 44,911 | +17.7% | 0.00% | 0.0% |
| Q1 2018 | $975,000 | +33.7% | 38,161 | -3.4% | 0.00% | +100.0% |
| Q4 2017 | $729,000 | +94.4% | 39,499 | +10.5% | 0.00% | 0.0% |
| Q3 2017 | $375,000 | -25.4% | 35,747 | -11.1% | 0.00% | 0.0% |
| Q2 2017 | $503,000 | +51.1% | 40,195 | +21.5% | 0.00% | 0.0% |
| Q1 2017 | $333,000 | -37.1% | 33,095 | -2.6% | 0.00% | 0.0% |
| Q4 2016 | $529,000 | -4.3% | 33,995 | +18.5% | 0.00% | 0.0% |
| Q3 2016 | $553,000 | +64.6% | 28,695 | +1.1% | 0.00% | 0.0% |
| Q2 2016 | $336,000 | +14.7% | 28,395 | +76.0% | 0.00% | 0.0% |
| Q1 2016 | $293,000 | -14.1% | 16,137 | +30.3% | 0.00% | 0.0% |
| Q4 2015 | $341,000 | +26.8% | 12,382 | +1.6% | 0.00% | 0.0% |
| Q3 2015 | $269,000 | +24.0% | 12,182 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $217,000 | – | 12,182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |